Vergleich

APP/beta-Amyloid (E737) polyclonal antibody

Hersteller Bioworld Technology, Inc
Kategorie
Typ Antibody Polyclonal
Specific against Human, Mouse, Rat
Applikationen WB, IF, IHC
Menge 50ul
Host Rabbit
ArtNr BS1011-50
Targets APP
eClass 6.1 32160702
eClass 9.0 32160702
Lieferbar
Swiss-Prot
P05067
Application all
WB: 1:500ca.1:1000
IHC: 1:50ca.1:200
IF: 1:50ca.1:200
Background
Proteolytic cleavage of the Amyloid protein precursor (APP) gives rise to the beta-Amyloid and Amyloid A4 proteins, which are present in human platelets. Amyloid deposition is associated with type II diabetes, Down syndrome and a variety of neurological disorders, including Alzheimer's disease. The Amyloid precursor protein (APP) undergoes alternative splicing, resulting in several isoforms. Proteolytic cleavage of APP leads to the formation of the Amyloid beta/A4 Amyloid protein. This protein is involved in the formation of neurofibrillary tangles and plaques that characterize the senile plaques of Alzheimer's patients. APLP1 (Amyloid precursor-like protein 1) and APLP2 are structurally similar to APP.
Product
1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2.
Purification and Purity
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Storage and Stability
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Specificity
APP/beta-Amyloid (E737) pAb detects endogenous levels of several isoforms of both mature and immature beta-amyloid A4 precursor protein, including APP639, APP677, APP695, APP696, APP714, APP733, APP751 and APP752.
WB
Western blot (WB) analysis of APP/beta-Amyloid (E737) pAb at 1:500 dilution
Lane1:MCF-7 cell lysate
Lane2:sp2/0 cell lysate
Lane3:H9C2 cell lysate
IHC
Immunohistochemistry (IHC) analyzes of APP/beta-Amyloid (E737) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
BiowMW
ca. 70 to140 kDa
Note
For research use only, not for use in diagnostic procedure.
Alternative Name
Amyloid beta A4 protein, ABPP, APPI, Short name=APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, Short name=CVAP, PreA4, Protease nexin-II, Short name=PN-II, N-APP, Soluble APP-alpha, Short name=S-APP-alpha, Soluble APP-beta, Short name=S-APP-beta, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, P3(42), P3(40), Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, Short name=AICD-59, Short name=AID(59), Gamma-CTF(59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, Short name=AICD-57, Short name=AID(57), Gamma-CTF(57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50), APP, A4, AD, Amyloid-beta, Amyloid beta, Amyloidbeta, beta Amyloid, betaAmyloid, Abeta
Immunogen
Synthetic peptide, corresponding to amino acids 701-750 of Human APP/beta-Amyloid.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50ul
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen